We show that the impact of GSK3B and CTNNB1 to this signature is not dependent on chemotherapy and more likely reflects a property of the primary tumour and our data further suggest, that in particular NOTCH2 might play a role for chemotherapy resistance in GC. The gene discussed is NOTCH2; the disease is neoplasm.